- Business
- The Cannabist Company Holdings Inc. (CBST.NE) cultivates, manufactures, and provides cannabis products and related services for medical and adult-use markets across 13 U.S. jurisdictions; operates approximately 95 facilities, including 73 dispensaries under the Cannabist retail brand and 22 cultivation and manufacturing sites; and offers flower, concentrates, edibles, oils, tablets, and accessories under brands such as Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, Amber, and dreamt. Founded in 2012 and headquartered at 321 Billerica Road, Chelmsford, Massachusetts, the company--formerly Columbia Care Inc., which rebranded in September 2023--delivers to diverse customers via a national dispensary network leveraging proprietary technology platforms. In August 2024, it enters definitive agreements totaling $16.4 million to divest its 14 Florida dispensaries, two cultivation and manufacturing facilities, and related medical marijuana treatment center license to MINT Cannabis, Shango, and a joint venture partner, enabling a footprint rationalization and focus on higher-growth markets; additionally, it closes the approximately $10 million sale of its Pennsylvania affiliate to VP Holdings in August 2025, repositioning toward wholesale strategies. The company employs 1,681 people and generates revenue primarily from U.S. pharmaceuticals, with 2024 sales at $459 million.